Incyte CorpINCY
Price$117.14Intrinsic value$120.042% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5.4B+26.4% YoYTTM through 31 Mar 2026
Net Income $1.4B+4,289.9% YoYTTM through 31 Mar 2026
Free Cash Flow $1.4BTTM through 31 Mar 2026

Margins

Current
Gross Margin91.8%
EBITDA Margin31.8%
Operating Margin23.7%
Net Margin26.7%

Returns

25.5%ROE
19.5%ROA
65.0%ROIC

Balance Sheet Health

Debt / Equity0.01x
Current Ratio3.67x
Net Debt-$4Bnet cash position
Cash & Equivalents$3.5B

Quality Metrics

Altman Z-Score11.20
Piotroski F-Score7 / 9
FCF Margin25.2%
Rule of 4036.0
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $5.1B
Diluted EPS$7.08TTM
'19'20'21'22'23'24'25
FY2025: $6.41

Dividend

No dividend

Capital Allocation

R&D Spend$2.1B
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.